Literature DB >> 3035374

Development of cytomegalovirus (CMV) retinitis in a patient with AIDS during ganciclovir therapy for CMV colitis.

J J O'Donnell, M A Jacobson, J Mills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035374     DOI: 10.1056/NEJM198706183162516

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome.

Authors:  C V DeRodriguez; J Fuhrer; G Lake-Bakaar
Journal:  J R Soc Med       Date:  1994-04       Impact factor: 5.344

2.  Efficacy of S26308 against guinea pig cytomegalovirus infection.

Authors:  M Chen; B P Griffith; H L Lucia; G D Hsiung
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 3.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

4.  Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

Authors:  Z H Yang; H L Lucia; R L Tolman; R J Colonno; G D Hsiung
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  In vivo antiherpesvirus activity of N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine.

Authors:  J Neyts; G Jähne; G Andrei; R Snoeck; I Winkler; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

Authors:  J Neyts; H Sobis; R Snoeck; M Vandeputte; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

7.  A chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development.

Authors:  Dabbu Kumar Jaijyan; Kavitha Govindasamy; Moses Lee; Hua Zhu
Journal:  Cell Rep Methods       Date:  2022-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.